Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital - 24/12/22
Doi : 10.1016/j.jinf.2022.11.001
Annalisa Mondi 1, ⁎, Roberta Gagliardini 1, ⁎, ⁎ 
, Valentina Mazzotta 1, Serena Vita 1, Fabrizio Carletti 2, Carmela Pinnetti 1, Maria Letizia Giancola 1, Eliana Specchiarello 2, Simone Lanini 1, Francesca Faraglia 1, Claudia Minosse 2, Jessica Paulicelli 1, Andrea Mariano 1, Gabriella Rozera 2, Carla Fontana 3, Paolo Faccendini 4, Fabrizio Maggi 2, Enrico Girardi 5, Francesco Vaia 6, Emanuele Nicastri 1, Andrea Antinori 1
, Valentina Mazzotta 1, Serena Vita 1, Fabrizio Carletti 2, Carmela Pinnetti 1, Maria Letizia Giancola 1, Eliana Specchiarello 2, Simone Lanini 1, Francesca Faraglia 1, Claudia Minosse 2, Jessica Paulicelli 1, Andrea Mariano 1, Gabriella Rozera 2, Carla Fontana 3, Paolo Faccendini 4, Fabrizio Maggi 2, Enrico Girardi 5, Francesco Vaia 6, Emanuele Nicastri 1, Andrea Antinori 1 1 Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy;
2 Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy;
3 Laboratory of Microbiology and Biological Bank, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy;
4 Pharmacy Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy;
5 Scientific Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
6 General Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
#Corresponding author: Dr. Roberta Gagliardini, Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Via Portuense 292, 00149 Rome, Italy, 0039 3331045103, 0039 0655170368Clinical and Research Infectious Diseases DepartmentNational Institute for Infectious Diseases Lazzaro Spallanzani IRCCSVia Portuense 292Rome00149Italy
Keywords : Monkeypox, tecovirimat, cidofovir, MPXV, Orthopoxvirus
Le texte complet de cet article est disponible en PDF.
Plan
© 2022
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 86 - N° 1
P. 66-117 - janvier 2023 Retour au numéro
Article précédent
- Pre-admission RT-qPCR based RSV screening reduces nosocomial RSV infections during epidemic outbreaks
- Francesco Pegoraro, Federica Barbati, Laura Pisano, Maria Moriondo, Caterina Pelosi, Lorenzo Lodi, Silvia Ricci, Giuseppe Indolfi, Chiara Azzari
- Multidrug-resistant infection in COVID-19 patients: A meta-analysis
- Siqi Hu, Yao You, Shenghui Zhang, Jiake Tang, Chen Chen, Wen Wen, Chunyi Wang, Yongran Cheng, Mengyun Zhou, Zhanhui Feng, Tao Tan, Guanming Qi, Mingwei Wang, Xiaoyan Liu
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?